| Typicality: | 0.311 |
| Saliency: | 0.145 |
| in unit dose form | 2 | other |
| invention → be directed to → pharmaceutical compositions | 5 |
| invention → be directed to → pharmaceutical composition | 4 |
| negative | neutral | positive |
| 0.068 | 0.798 | 0.134 |
| Raw frequency | 9 |
| Normalized frequency | 0.145 |
| Modifier score | 0.500 |
| Perplexity | 46.935 |